AFC-HD AMS Life Science Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Feb'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Feb 2026 is -1.49% vs 8.61% in Feb 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Feb 2026 is -38.25% vs 42.99% in Feb 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'26",
        "Feb'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,298.60",
          "val2": "8,424.50",
          "chgp": "-1.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "837.50",
          "val2": "994.40",
          "chgp": "-15.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "60.20",
          "val2": "47.60",
          "chgp": "26.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "61.40",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "284.50",
          "val2": "460.70",
          "chgp": "-38.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "57.80%",
          "val2": "76.50%",
          "chgp": "-1.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2025 is 8.18% vs 18.01% in Aug 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2025 is 17.94% vs 12.54% in Aug 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Aug'25",
        "Aug'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32,655.00",
          "val2": "30,185.50",
          "chgp": "8.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,777.30",
          "val2": "3,011.80",
          "chgp": "25.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "201.20",
          "val2": "101.30",
          "chgp": "98.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-218.70",
          "val2": "-33.00",
          "chgp": "-562.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,468.80",
          "val2": "1,245.40",
          "chgp": "17.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.90%",
          "val2": "63.80%",
          "chgp": "0.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Feb'26 - YoY

Feb'26

Feb'25

Change(%)

Net Sales

8,298.60

8,424.50

-1.49%

Operating Profit (PBDIT) excl Other Income

837.50

994.40

-15.78%

Interest

60.20

47.60

26.47%

Exceptional Items

0.00

61.40

-100.00%

Consolidate Net Profit

284.50

460.70

-38.25%

Operating Profit Margin (Excl OI)

57.80%

76.50%

-1.87%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Feb 2026 is -1.49% vs 8.61% in Feb 2025

Consolidated Net Profit

YoY Growth in quarter ended Feb 2026 is -38.25% vs 42.99% in Feb 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Aug'25

Aug'25

Aug'24

Change(%)

Net Sales

32,655.00

30,185.50

8.18%

Operating Profit (PBDIT) excl Other Income

3,777.30

3,011.80

25.42%

Interest

201.20

101.30

98.62%

Exceptional Items

-218.70

-33.00

-562.73%

Consolidate Net Profit

1,468.80

1,245.40

17.94%

Operating Profit Margin (Excl OI)

72.90%

63.80%

0.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Aug 2025 is 8.18% vs 18.01% in Aug 2024

Consolidated Net Profit

YoY Growth in year ended Aug 2025 is 17.94% vs 12.54% in Aug 2024

All Annual Results